Skip to main content
. 2024 Nov 15;15:21514593241273326. doi: 10.1177/21514593241273326

Table 2.

Patient Outcomes.

Study Intervention N Non-union Internal Fixture Loosening/Failure Other Postoperative Complications Reoperation Mortality P values Reported Conclusions
He, 2021 13 Cannulated screw 36 5.6% (2/36) 8.3% (3/36) Femoral neck shortening: 8.3% (3/36) -- -- -- FNS had a lower incidence of overall complications (combining non-union, nail retreat, femoral neck shortening, and internal fixation cutout)
FNS (DePuy synthes) 33 0.0% (0/33) 3.0% (1/33) Femoral neck shortening: 3.0% (1/33) -- --
Hu, 2021 14 Cannulated screw 24 12.5% (3/24), P = 0.795 -- AVN: 12.5% (3/24), Femoral neck shortening: 4.54±2.75 mm
37.5% (9/24)
-- -- AVN: P = 0.389 a
Femoral neck shortening length: P = 0.005 b
Femoral neck shortening incidence: P = 0.036 a
FNS had a lower degree of femoral neck shortening and a lower incidence femoral neck shortening, but no difference in incidence of non-union or AVN.
FNS (DePuy synthes) 20 10.0% (2/20) -- AVN: 5.0% (1/20)
Femoral neck shortening: 2.40±1.81 mm
10.0% (2/20)
-- --
Nibe, 2021 15 Cannulated screw 27 18.5% (5/27) 7.4% (2/27) -- Overall: 28.6% (6/21)
Conversion to HA: 11.1% (3/27)
Implant removal: 11.1% (3/27)
-- Non-union: P = 0.052 c
Overall reoperation: P = 0.023 c
FNS had a significantly lower incidence of reoperation
FNS (DePuy synthes) 25 0.0% (0/25) -- -- 0.0% (0/25) --
Tang, 2021 19 Cannulated screw 45 8.9% (4/45) 11.1% (5/45) AVN: 6.7% (3/45)
DVT: 0.0% (0/45)
-- -- Non-union: P = 0.430 a
Internal fixture loosening/failure: P = 0.481 a
AVN: P = 0.356 a
The interventions had no significant differences in patient outcomes
FNS (DePuy synthes) 47 4.3% (2/47) 6.4% (3/47) AVN: 2.1% (1/47)
DVT: 0.0% (0/47)
-- --
Vazquez, 2021 20 Cannulated screw 32 -- -- 3.1% (1/32) 9.4% (3/32) Mortality: P = 0.585 c The interventions had no significant differences in patient outcomes
Dynamic or sliding hip screw 16 -- -- -- 0.0% (0/16) 12.5% (2/16)
FNS (DePuy synthes) 15 -- -- -- 0.0% (0/15) 0.0% (0/15)
Zhang, 2022 22 Cannulated screw 36 -- -- Femoral neck shortening: 13.89% (5/36) Implant removal: 13.89% (5/36) 0.0% (0/36) Femoral neck shortening: P = 0.282 a
Implant removal: P = 0.026 a
FNS had a lower incidence of implant removal
FNS (DePuy synthes) 33 -- -- Femoral neck shortening: 6.06% (2/33) Implant removal: 0.0% (0/33) 0.0% (0/33)
Zhou, 2021 23 Cannulated screw 51 -- -- AVN: 0.0% (1/51)
DVT: 0.0% (0/51)
Conversion to HA: 3.9% (2/51) -- -- FNS had a lower incidence of overall complications
FNS (DePuy synthes) 30 -- -- AVN: 0.0% (0/30)
DVT: 0.0% (0/30)
Conversion to HA: 3.3% (1/30) --
Niemann, 2022 16 Dynamic or sliding hip screw 19 -- -- AVN: 0.0% (0/19)
Femoral neck shortening: 0.0% (0/19)
Femoral neck shortening: 0.0% (0/12)
-- -- -- The interventions had no significant differences in patient outcomes
FNS (DePuy synthes) 12 -- -- AVN: 0.0% (0/12) -- -- --
Schuetze, 2022 17 Dynamic or sliding hip screw 108 -- 10.2% (11/108) Femoral neck shortening: 4.8±2.1 mm
27.7% (30/108)
Hematoma: 5.6% (6/108)
Surgical site infection: 2.8% (3/108)
Conversion to THA: 8.3% (9/108)
Implant removal: 1.9% (2/108)
0.9% (1/108) Failure, hematoma, or infection: P = 0.479 d
Femoral neck shortening: 0.455 d
Mortality: >0.05 d
The interventions had no significant differences in patient outcomes
FNS (DePuy synthes) 113 -- 12.4% (14/113) Femoral neck shortening: 5.3±1.9 mm
27.4% (31/113)
Hematoma: 0.9% (1/113)
Surgical site infection: 0.0% (0/113)
Conversion to THA: 11.5% (13/113)
Implant removal: 0.9% (1/113)
3.5% (4/113)
Xu, 2022 21 Cancellous screw 51 -- 3.9% (2/51) AVN: 0.0% (0/51)
DVT: 0.0% (0/51)
Femoral neck shortening: 1.9 mm (0.2-3.5)
-- -- Internal fixture loosening/failure: P = 1.000 c
Femoral neck shortening: P = 0.452 e
The interventions had no significant differences in patient outcomes
Dynamic or sliding hip screw 52 -- 3.8% (2/52) AVN: 0.0% (0/52)
DVT: 0.0% (0/52)
Femoral neck shortening: 2.0 mm (0.2-4.8)
-- --
FNS (DePuy synthes) 54 -- 5.6% (3/54) AVN: 0.0% (0/54)
DVT: 0.0% (0/54)
Femoral neck shortening: 2.2 mm (0.4-4.1)
-- --
Cintean, 2021 11 FNS (DePuy synthes) 29 -- -- AVN: 0.0% (0/21)
Femoral neck shortening: 3.3±4.5 mm, 100.0% (21/21)
Overall: 13.8% (4/29)
Conversion to hemiarthroplasty: 10.3% (3/29)
Removal of implant: 3.4% (1/29)
6.9% (2/29) Mortality: P = 0.663 c The interventions had no significant difference in patient outcomes
Hemiarthroplasty 34 -- -- -- Overall: 8.8% (3/34)
Conversion to HA: 2.9% (1/34)
8.8% (3/34)
Non-comparative studies
 Davidson, 2022 12 FNS (DePuy synthes) 102 1.0% (1/102) 1.0% (1/102) AVN: 2.9% (3/102) Conversion to THA: 8.8% (9/102) 0.0% (0/102) -- No comparison between interventions
 Stassen, 2021 18 FNS (DePuy synthes) 34 -- 5.9% (2/34) AVN: 11.8% (4/34) Conversion to THA: 17.6% (6/34)
Implant removal: 5.9% (2/34)
0.0% (0/34) -- No comparison between interventions

Data are expressed as mean ± SD, median (IQR), or % (n) unless otherwise indicated. “--“ indicates no data reported.

AVN = avascular necrosis; DVT = deep vein thrombosis; FNS = Femoral Neck System; HA = hip arthroplasty; THA = total hip arthroplasty.

aChi-squared test of independence.

bIndependent-samples t-test.

cFisher's exact test.

dStatistical methods not clearly reported.

eKruskal-Wallis test.